Skyrizi 180 MG/1.2 ML on-body 1.2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FFK4E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,467
Award facts
- Contract value 100% obligated
- $12,467.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $12,467 firm fixed-price delivery order to AmerSourceBergen Drug Corp on January 8, 2026, for the supply of SKYRIZI 180 MG/1.2 ML on-body injector units. The contract, which carries an ultimate completion date of January 30, 2026, was awarded on a non-set-aside, competitive basis. AmerSourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare systems. The delivery order is issued under AmerSourceBergen's parent company, Cencora, Inc., which holds a substantial indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2031.
This delivery order represents a task order execution under Cencora's comprehensive pharmaceutical prime vendor IDC, which provides global pharmaceutical support across multiple therapeutic domains including specialty medications, brand-name and generic drugs, and medical devices. SKYRIZI (risankizumab), a biologic immunosuppressant used primarily for dermatological and gastrointestinal conditions, is being procured to support military healthcare programs and Defense Health Agency requirements. The award demonstrates AmerSourceBergen's continued capability to competitively fulfill federal medical supply needs through its extensive pharmaceutical distribution network.
Quick answers
Who was awarded contract SPE2DR26FFK4E?
SPE2DR26FFK4E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FFK4E worth?
The government has obligated $12,467 on SPE2DR26FFK4E.
Is contract SPE2DR26FFK4E an order under another contract?
Yes. SPE2DR26FFK4E is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFK4E competed?
The extent of competition for SPE2DR26FFK4E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award